182 related articles for article (PubMed ID: 9453596)
21. Mucosal immunization with a Staphylococcus aureus IsdA-cholera toxin A2/B chimera induces antigen-specific Th2-type responses in mice.
Arlian BM; Tinker JK
Clin Vaccine Immunol; 2011 Sep; 18(9):1543-51. PubMed ID: 21734065
[TBL] [Abstract][Full Text] [Related]
22. Immunodulation of rat serum and mucosal antibody responses to Entamoeba histolytica trophozoites by beta-1,3-glucan and cholera toxin.
Navarro-García F; Pedroso M; López-Revilla R
Clin Immunol; 2000 Nov; 97(2):182-8. PubMed ID: 11027459
[TBL] [Abstract][Full Text] [Related]
23. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
24. Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection.
Olivera N; Castuma CE; Hozbor D; Gaillard ME; Rumbo M; Gómez RM
Biomed Res Int; 2014; 2014():421486. PubMed ID: 24982881
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal study of the antibody response to recombinant Entamoeba histolytica antigens in patients with amebic liver abscess.
Stanley SL; Jackson TF; Foster L; Singh S
Am J Trop Med Hyg; 1998 Apr; 58(4):414-6. PubMed ID: 9574784
[TBL] [Abstract][Full Text] [Related]
26. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
27. Immunizing adult female mice with a TcpA-A2-CTB chimera provides a high level of protection for their pups in the infant mouse model of cholera.
Price GA; Holmes RK
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3356. PubMed ID: 25474636
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.
Harokopakis E; Hajishengallis G; Michalek SM
Infect Immun; 1998 Sep; 66(9):4299-304. PubMed ID: 9712781
[TBL] [Abstract][Full Text] [Related]
29. Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.
Harakuni T; Sugawa H; Komesu A; Tadano M; Arakawa T
Infect Immun; 2005 Sep; 73(9):5654-65. PubMed ID: 16113283
[TBL] [Abstract][Full Text] [Related]
30. Formulation of HIV-envelope protein with lipid vesicles expressing ganglioside GM1 associated to cholera toxin B enhances mucosal immune responses.
Lian T; Bui T; Ho RJ
Vaccine; 1999 Nov; 18(7-8):604-11. PubMed ID: 10547418
[TBL] [Abstract][Full Text] [Related]
31. Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity.
Yuki Y; Tokuhara D; Nochi T; Yasuda H; Mejima M; Kurokawa S; Takahashi Y; Kataoka N; Nakanishi U; Hagiwara Y; Fujihashi K; Takaiwa F; Kiyono H
Vaccine; 2009 Oct; 27(43):5982-8. PubMed ID: 19665603
[TBL] [Abstract][Full Text] [Related]
32. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine.
Abd Alla MD; White GL; Rogers TB; Cary ME; Carey DW; Ravdin JI
Infect Immun; 2007 Aug; 75(8):3812-22. PubMed ID: 17526742
[TBL] [Abstract][Full Text] [Related]
33. Cholera toxin B subunit-five-stranded α-helical coiled-coil fusion protein: "five-to-five" molecular chimera displays robust physicochemical stability.
Arakawa T; Harakuni T
Vaccine; 2014 Sep; 32(39):5019-26. PubMed ID: 25045819
[TBL] [Abstract][Full Text] [Related]
34. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
Matoba N; Geyer BC; Kilbourne J; Alfsen A; Bomsel M; Mor TS
Vaccine; 2006 Jun; 24(23):5047-55. PubMed ID: 16621185
[TBL] [Abstract][Full Text] [Related]
35. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.
Houpt E; Barroso L; Lockhart L; Wright R; Cramer C; Lyerly D; Petri WA
Vaccine; 2004 Jan; 22(5-6):611-7. PubMed ID: 14741152
[TBL] [Abstract][Full Text] [Related]
36. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
Bckström M; Holmgren J; Schödel F; Lebens M
Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
[TBL] [Abstract][Full Text] [Related]
37. Plant-synthesized E. coli CFA/I fimbrial protein protects Caco-2 cells from bacterial attachment.
Lee JY; Yu J; Henderson D; Langridge WH
Vaccine; 2004 Nov; 23(2):222-31. PubMed ID: 15531041
[TBL] [Abstract][Full Text] [Related]
38. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits.
Hajishengallis G; Hollingshead SK; Koga T; Russell MW
J Immunol; 1995 May; 154(9):4322-32. PubMed ID: 7722290
[TBL] [Abstract][Full Text] [Related]
39. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
Price GA; Russell MW; Cornelissen CN
Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
[TBL] [Abstract][Full Text] [Related]
40. Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in mice.
Arêas AP; Oliveira ML; Miyaji EN; Leite LC; Aires KA; Dias WO; Ho PL
Biochem Biophys Res Commun; 2004 Aug; 321(1):192-6. PubMed ID: 15358234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
